XML 113 R100.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment reporting - results of operations of reportable segments (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Aug. 31, 2022
May 31, 2022
Feb. 28, 2022
Nov. 30, 2021
Aug. 31, 2021
May 31, 2021
Feb. 28, 2021
Nov. 30, 2020
Aug. 31, 2022
Aug. 31, 2021
Aug. 31, 2020
Segment Reporting Information, Operating Income (Loss) [Abstract]                      
Sales $ 32,449 $ 32,597 $ 33,756 $ 33,901 $ 34,262 $ 34,030 $ 32,779 $ 31,438 $ 132,703 $ 132,509 $ 121,982
Adjusted operating income                 5,133 5,117 4,730
Depreciation and amortization                 1,990 1,923 1,786
Capital expenditures                 1,734 1,312 1,287
Acquisition-related amortization                 (855) (523) (384)
Impairment of goodwill and intangible assets                 (783) (49) (2,016)
Certain legal and regulatory accruals and settlements                 (768) (75) 0
Transformational cost management                 (763) (417) (719)
Acquisition-related costs                 (223) (54) (315)
Adjustments to equity earnings (loss) in AmerisourceBergen                 (218) (1,645) (97)
LIFO provision                 (135) (13) (95)
Store optimization                 0 0 (53)
Store damage and inventory losses                 0 0 (68)
Operating income                 1,387 2,342 982
Reportable Segments | U.S. Retail Pharmacy                      
Segment Reporting Information, Operating Income (Loss) [Abstract]                      
Sales                 109,078 112,005 107,701
Adjusted operating income                 5,029 5,019 4,761
Depreciation and amortization                 1,415 1,513 1,376
Capital expenditures                 1,207 1,030 1,040
Reportable Segments | International                      
Segment Reporting Information, Operating Income (Loss) [Abstract]                      
Sales                 21,830 20,505 14,281
Adjusted operating income                 726 466 157
Depreciation and amortization                 355 399 400
Capital expenditures                 295 243 235
Reportable Segments | Walgreens health                      
Segment Reporting Information, Operating Income (Loss) [Abstract]                      
Sales                 1,795 0 0
Adjusted operating income                 (370) (57) 0
Depreciation and amortization                 211 1 0
Capital expenditures                 218 34 0
Corporate and Other                      
Segment Reporting Information, Operating Income (Loss) [Abstract]                      
Adjusted operating income                 (251) (311) (187)
Depreciation and amortization                 9 10 10
Capital expenditures                 $ 15 $ 5 $ 12